Cell X Technologies develops the Celligent™ platform, which integrates robotics, imaging, and artificial intelligence to automate and optimize cell processing for stem cell research and cell manufacturing. This technology addresses the challenges of achieving consistent, reproducible, and GMP-compliant processes necessary for the commercialization of cellular therapies and tissue engineering applications.
Funding
$9.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cellular therapy and tissue engineering applications face challenges in achieving consistent, reproducible, and GMP-compliant cell processing, hindering the commercialization of these advanced therapies. Manual cell processing methods are prone to human error and variability, impacting cell quality and scalability.
Solution
Cell X Technologies offers the Celligent™ platform, an integrated system combining robotics, imaging, and artificial intelligence to automate and optimize cell processing. The platform enables consistent, reproducible, and scalable GMP-compliant processes for cell therapies, tissue engineering, and artificial organ development. By automating cell handling, selection, and culture, Celligent™ reduces human error and contamination, while generating detailed annotations of each action and decision point. The system's machine learning capabilities leverage a CxKnowledge data bank to guide experimental design and improve processes, accelerating the development and commercialization of cell-based therapies.
Target Audience
The primary target audience includes researchers and manufacturers in the fields of cellular therapies, stem cell-derived therapies, tissue engineering, and artificial organs seeking to automate and optimize their cell processing workflows.
Features
- BioAdaptive Automation™: Automated weeding, picking, biopsying, media changing, and passaging in response to biological cues.
- Integrated imaging for real-time monitoring of cell proliferation rate and colony analysis.
- Machine learning-driven platform that expands its capabilities with each new program.
- CxKnowledge data bank: A repository of information generated from past experiments and outcomes to guide Design of Experiments (DoE).
- Comprehensive data collection and analytics integration for streamlining regulatory filings.
- 21 CFR Part 11 Compliance for GMP Operations.
- Automated annotation of each action and decision point during cell processing.
- Atraumatic picking & biopsying, positive & negative cell selection.